--- title: "MANNATECH INC (MTEX) stock: news and investor profile" url: "https://aibio.space/companies/mannatech/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "MANNATECH INC (NASDAQ: MTEX), United States. Listing facts, related biotech companies and news on aibio.space." --- MTEX MANNATECH INC NASDAQ · United States # MANNATECH INC (MTEX) news Listings · 2026-10-14 ## [Mannatech says it regained Nasdaq stockholders' equity compliance](https://aibio.space/news/mannatech-says-regained-nasdaq-stockholders-equity-compliance/) Mannatech said a Swiss holding company transaction and a pro forma tax adjustment put it back above Nasdaq's stockholders' equity minimum, subject to review and to Nasdaq's view. ## Latest MANNATECH INC news 1. 2026-08-12 Company Updates [Mannatech reports second quarter 2026 net income of $1.0 million](https://aibio.space/news/mannatech-reports-second-quarter-2026-net-income-1-0-million/) Net sales rose to $26.7 million for the quarter ended June 30, 2026, and the company reported net income after a net loss a year earlier. ## MANNATECH INC at a glance - **Ticker**: MTEX - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $6.0 million ### Related companies - [HAEMONETICS CORP](https://aibio.space/companies/haemonetics/) NYSE: HAE - [Penumbra](https://aibio.space/companies/penumbra/) NYSE: PEN - [NEOGENOMICS INC](https://aibio.space/companies/neogenomics/) NASDAQ: NEO - [Vivos Therapeutics](https://aibio.space/companies/vivos-therapeutics/) NASDAQ: VVOS - [GUIDED THERAPEUTICS INC](https://aibio.space/companies/guided-therapeutics/) OTC: GTHP - [Genenta Science S.p.A.](https://aibio.space/companies/genenta-science-s-p-a/) NASDAQ: GNTA - [EDAP TMS SA](https://aibio.space/companies/edap-tms/) NASDAQ: FOCL - [MYOMO, INC.](https://aibio.space/companies/myomo/) NYSE: MYO ### Also on NASDAQ - [AquaBounty Technologies](https://aibio.space/companies/aquabounty-technologies/) AQB - [Avalyn Pharma](https://aibio.space/companies/avalyn-pharma/) AVLN - [Amylyx Pharmaceuticals](https://aibio.space/companies/amylyx-pharmaceuticals/) AMLX - [SAB Biotherapeutics](https://aibio.space/companies/sab-biotherapeutics/) SABS - [CERUS CORP](https://aibio.space/companies/cerus/) CERS - [Caris Life Sciences](https://aibio.space/companies/caris-life-sciences/) CAI ## MANNATECH INC annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$108.0 million](https://www.sec.gov/Archives/edgar/data/1056358/000143774926012430/) | [$117.9 million](https://www.sec.gov/Archives/edgar/data/1056358/000143774926012430/) | | Research and development | [$800,000](https://www.sec.gov/Archives/edgar/data/1056358/000143774926012430/) | [$700,000](https://www.sec.gov/Archives/edgar/data/1056358/000143774926012430/) | | Net income (loss) | [-$15.2 million](https://www.sec.gov/Archives/edgar/data/1056358/000143774926012430/) | [$2.5 million](https://www.sec.gov/Archives/edgar/data/1056358/000143774926012430/) | | Cash from operations | [-$3.0 million](https://www.sec.gov/Archives/edgar/data/1056358/000143774926012430/) | [$2.3 million](https://www.sec.gov/Archives/edgar/data/1056358/000143774926012430/) | | Cash and equivalents | [$6.2 million](https://www.sec.gov/Archives/edgar/data/1056358/000143774926027304/) | [$11.4 million](https://www.sec.gov/Archives/edgar/data/1056358/000143774926012430/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $6.0 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about MANNATECH INC What is the ticker symbol of MANNATECH INC? MANNATECH INC trades under the ticker MTEX on NASDAQ. Where is MANNATECH INC listed? MANNATECH INC is listed on NASDAQ. Which country or territory is MANNATECH INC listed under? Our directory records MANNATECH INC under United States. Does aibio.space cover MANNATECH INC? aibio.space lists MANNATECH INC among 2,820 public biotech companies and publishes its news here as stories appear. What was MANNATECH INC's revenue last year? $108.0 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is MANNATECH INC profitable? MANNATECH INC reported a net loss of $15.2 million for the fiscal year ended Dec 31, 2025, and used $3.0 million of cash in operations, per its annual report to the SEC. How much does MANNATECH INC spend on research and development? $800,000 in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does MANNATECH INC have? $6.0 million in cash at Jun 30, 2026, per its 10-Q. What is the latest MANNATECH INC (MTEX) stock news? Our latest story on MANNATECH INC, dated Oct 14, 2026: "Mannatech says it regained Nasdaq stockholders' equity compliance". Mannatech said a Swiss holding company transaction and a pro forma tax adjustment put it back above Nasdaq's stockholders' equity minimum, subject to review and to Nasdaq's view. [Source](https://aibio.space/news/mannatech-says-regained-nasdaq-stockholders-equity-compliance/). Is MANNATECH INC at risk of delisting? Our latest listing story, dated Oct 14, 2026: "Mannatech says it regained Nasdaq stockholders' equity compliance". Mannatech said a Swiss holding company transaction and a pro forma tax adjustment put it back above Nasdaq's stockholders' equity minimum, subject to review and to Nasdaq's view. [Source](https://aibio.space/news/mannatech-says-regained-nasdaq-stockholders-equity-compliance/). How can I follow MANNATECH INC (MTEX) news? Press Follow on this page to add MANNATECH INC to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming MANNATECH INC so far, in Company Updates, Listings. ## Investor discussion: MANNATECH INC Members talk about MANNATECH INC (MTEX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at MANNATECH INC, newest first. Each line links the filing it comes from. 1. 2026-10-21 Legal Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1056358/000143774926033029/mtex20261012c_8k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:MTEX on TradingView](https://www.tradingview.com/symbols/NASDAQ-MTEX/). ## Listing details MANNATECH INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker MTEX, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: MANNATECH INC - **Ticker**: MTEX - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/mannatech/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "MANNATECH INC (MTEX) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/mannatech/